Raloxifene Hydrochloride Tablets, USP 60 mg 30 count Recall

American Health Packaging has initiated a voluntary drug recall for Raloxifene Hydrochloride Tablets, USP 60 mg ...

See details

Open Recalls

Recalled product should not be sent directly to American Health Packaging. It should be sent to the third party recall provider described when following directions in the recall notification. Thank you for your assistance and cooperation.

December 2019

Raloxifene Hydrochloride Tablets, USP 60 mg

Carton NDC: 60687-266-21; Blister NDC: 60687-266-11

Download recall letter

Download response form

November 2019

Ranitidine Tablets, USP 150 mg

Carton NDC: 60687-322-01; Blister NDC: 60687-322-11
Note: AHP does not have access to supply of manufactured tablets or oral liquid product at this time, but is actively inquiring about availability from all current and future manufacturers. Unfortunately, it may be many months before the manufacturing industry can make Ranitidine products available.

Download recall letter

Download response form

Ranitidine Syrup (Ranitidine Oral Solution USP) 150 mg/10 mL

Case NDC: 60687-260-23; Tray NDC: 60687-260-48; Cup NDC: 60687-260-42
Case NDC: 60687-260-69; Tray NDC: 60687-260-48; Cup NDC: 60687-260-42
Note: AHP does not have access to supply of manufactured tablets or oral liquid product at this time, but is actively inquiring about availability from all current and future manufacturers. Unfortunately, it may be many months before the manufacturing industry can make Ranitidine products available.